GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » Days Sales Outstanding

Surgical Innovations Group (LSE:SUN) Days Sales Outstanding : 59.65 (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group Days Sales Outstanding?

Surgical Innovations Group's average Accounts Receivable for the six months ended in Dec. 2023 was £2.08 Mil. Surgical Innovations Group's Revenue for the six months ended in Dec. 2023 was £6.36 Mil. Hence, Surgical Innovations Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 59.65.

The historical rank and industry rank for Surgical Innovations Group's Days Sales Outstanding or its related term are showing as below:

LSE:SUN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.15   Med: 70.8   Max: 226.57
Current: 59.97

During the past 13 years, Surgical Innovations Group's highest Days Sales Outstanding was 226.57. The lowest was 47.15. And the median was 70.80.

LSE:SUN's Days Sales Outstanding is ranked better than
54.81% of 810 companies
in the Medical Devices & Instruments industry
Industry Median: 64.2 vs LSE:SUN: 59.97

Surgical Innovations Group's Days Sales Outstanding increased from Dec. 2022 (58.75) to Dec. 2023 (59.65).


Surgical Innovations Group Days Sales Outstanding Historical Data

The historical data trend for Surgical Innovations Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group Days Sales Outstanding Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.01 83.85 47.15 50.81 57.50

Surgical Innovations Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.36 58.14 58.75 62.97 59.65

Competitive Comparison of Surgical Innovations Group's Days Sales Outstanding

For the Medical Devices subindustry, Surgical Innovations Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's Days Sales Outstanding falls into.



Surgical Innovations Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Surgical Innovations Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (1.762 + 2.023) / 2 ) / 12.014*365
=1.8925 / 12.014*365
=57.50

Surgical Innovations Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (2.137 + 2.023) / 2 ) / 6.364*365 / 2
=2.08 / 6.364*365 / 2
=59.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgical Innovations Group  (LSE:SUN) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Surgical Innovations Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.

Surgical Innovations Group (LSE:SUN) Headlines

From GuruFocus

Sunoco LP Announces 1Q 2022 Earnings Release and Call Timing

By PRNewswire PRNewswire 04-18-2022

Sunoco LP Announces Availability of 2021 Schedule K-3s

By PRNewswire PRNewswire 08-29-2022

Sunoco LP Maintains Quarterly Distribution

By PRNewswire PRNewswire 04-26-2022

Sunoco LP Maintains Quarterly Distribution

By PRNewswire PRNewswire 01-25-2023

Sunoco LP's Dividend Analysis

By GuruFocus Research 10-26-2023

Sunoco LP Maintains Quarterly Distribution

By PRNewswire 10-20-2023